在急性前兆细胞白血病中失调的血静
1UNC Blood Research Center, Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, 116 Manning Drive, 8004 Mary Ellen Jones Bldg, Campus Box #7035, Chapel Hill, NC, 27599, USA. yohei_hisada@med.unc.edu.
International journal of hematology
|February 10, 2024
概括
急性前列细胞白血病 (APL) 导致早期死亡,主要是由于严重出血. 这项研究提出了四个关键的分子途径,有助于APL出血,旨在找到新的生物标志物和治疗方法.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 急性前列细胞白血病 (APL) 在诊断后30天内有很高的早期死亡率.
- 严重出血,特别是内出血,是APL患者早期死亡的主要原因.
- 虽然凝血激活,高纤维素溶解和血栓塞缩是已知的APL并发症,但确切的出血机制尚不清楚.
研究的目的:
- 为了阐明导致急性前兆细胞白血病严重出血的精确分子机制.
- 确定用于预测APL患者出血风险的新生物标志物.
- 引导开发针对APL相关出血的向治疗方法.
主要方法:
- 这项研究建议研究四种特定的分子通路,涉及到出血.
- 第1路径:组织因子.
- 途径2:泌尿酸酶等离子体激活剂/泌尿酸酶等离子体激活剂受体.
- 途径3:附件A2/S100A100/组织等离子素激活剂.
- 途径4:波多普拉宁/C型学菌素类受体 2.
主要成果:
- 拟议的研究旨在确定这四种途径对APL相关出血的贡献.
- 确定特定途径的参与对于理解APL病理生理学至关重要.
- 这项研究预计将为APL复杂的出血透析产生新的见解.
结论:
- 了解这四种途径对于改善APL患者的治疗结果至关重要.
- 这项研究将有助于发现出血风险的预测生物标志物.
- 这些发现将为开发新型治疗策略铺平道路,以预防和治疗APL的出血.
相关概念视频
01:24Disorders of Hemostasis
911
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
911
01:01Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
01:27Disorders of Leukocytes
953
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
953
01:22Formation of the Platelet Plug
6.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
7.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.7K
01:05Introduction to Hemostasis
7.7K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.7K